These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32571819)

  • 1. Characterization of Amikacin Drug Exposure and Nephrotoxicity in an Animal Model.
    Chan K; Ledesma KR; Wang W; Tam VH
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model.
    Hudson CS; Smith JE; Eales BM; Kajiji S; Liu X; Truong LD; Tam VH
    J Antimicrob Chemother; 2023 Oct; 78(10):2435-2441. PubMed ID: 37563789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative nephrotoxicity and tissue accumulation of dactimicin, amikacin and gentamicin.
    Bonadio M; Maccanti O; Giovannini L; Bertelli AA; Scalori V; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):747-50. PubMed ID: 3447878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonparallel nephrotoxicity dose-response curves of aminoglycosides.
    Hottendorf GH; Barnett D; Gordon LL; Christensen EF; Madissoo H
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1024-8. PubMed ID: 7271271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative nephrotoxicity of hydroxygentamicin and other aminoglycosides in rats.
    Slighter RG; Montenaro MJ; Fabian RJ; Bhandari JC; Donikian MR; Drobeck HP
    Fundam Appl Toxicol; 1984 Aug; 4(4):558-67. PubMed ID: 6479501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nephrotoxicity and renal accumulation of amikacin, tobramycin and gentamycin in rats, rabbits and guinea pigs.
    Sairio E; Kasanen A; Kangas L; Nieminen AL; Nieminen L
    Exp Pathol (Jena); 1978; 15(6):370-5. PubMed ID: 744211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design.
    Abdelraouf K; Braggs KH; Yin T; Truong LD; Hu M; Tam VH
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4625-9. PubMed ID: 22687519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of amikacin in noncritically ill patients
.
    Kim DJ; Lee J; Yu H; Lee DH; Kang T; Han YK; Kim DH; Kim SW
    Clin Nephrol; 2019 Oct; 92(4):201-207. PubMed ID: 31347498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
    Brion N; Barge J; Godefroy I; Dromer F; Dubois C; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):168-72. PubMed ID: 6712201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of aminoglycosides in young and adult rats.
    Provoost AP; Adejuyigbe O; Wolff ED
    Pediatr Res; 1985 Nov; 19(11):1191-6. PubMed ID: 4069829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Side effects of aminoglycosides: nephrotoxicity (author's transl)].
    Sack K; Freiesleben H; Züllich B; Beck H; Schulz E
    Infection; 1976; 4(4):231-8. PubMed ID: 65328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside dosages and nephrotoxicity: quantitative relationships.
    Rougier F; Ducher M; Maurin M; Corvaisier S; Claude D; Jelliffe R; Maire P
    Clin Pharmacokinet; 2003; 42(5):493-500. PubMed ID: 12739987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of haemodialysis as a protective technique for preventing high daily dose amikacin nephrotoxicity: an experimental study in an ovine model.
    Pouzot-Nevoret C; Magnin M; Ayoub JY; Bourguignon L; Maire P; Wertz D; Goy-Thollot I; Barthélemy A; Boselli E; Allaouchiche B; Bonnet-Garin JM
    Int J Antimicrob Agents; 2017 Aug; 50(2):148-154. PubMed ID: 28689868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
    Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes.
    Fillastre JP; Hemet J; Tulkens P; Morin JP; Viotte G; Olier B; Godin M
    Adv Nephrol Necker Hosp; 1983; 12():253-75. PubMed ID: 6404138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives.
    Tulkens PM
    Am J Med; 1986 Jun; 80(6B):105-14. PubMed ID: 3728522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
    Inouye S; Niizato T; Shomura T; Kitasato I
    Drugs Exp Clin Res; 1989; 15(5):189-209. PubMed ID: 2791871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A robust LC-MS/MS method for amikacin: application to cellular uptake and pharmacokinetic studies.
    Chan K; Wang W; Ledesma KR; Yin T; Tam VH
    Bioanalysis; 2020 Apr; 12(7):445-454. PubMed ID: 32343148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.